✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹4,705 Cr.
P/E
158.51

Key Ratios

Market cap
Market cap
4,705 Cr
PE
PE
158
Prom Holding
Prom Holding
52.61 %
ROE (%)
ROE (%)
3.11
ROCE (%)
ROCE (%)
10.65
Div Yield (%)
Div Yield (%)
-
Sales
Sales
1,602 Cr
OPM (%)
OPM (%)
10.73 %
Debt to Equity
Debt to Equity
0.73

About

SeQuent, an integrated pharmaceutical company founded in 2002, focuses on Animal Health (API a… Read more
Low
111
52W Range
High
241
  • Sequent Scientific
  • Zota Health Care
  • Guj. Themis Biosyn
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

10 %
(as of Mar 19)
Animal Healthcare - Market Share in Turkey
30 %
(as of Mar 19)
Losartan - Market Share in USA

Revenue mix

Product Wise Break-Up

Segment Break-Up - Formulation Business-By Dosage

Segment Break-Up - Formulation Business-By Species Type

Location Wise Break-Up - Formulations

Location Wise Break-Up

Therapeutic Area Break-Up - Formulations

Customer Segment

Dosage Form Break-Up

R&D Break-Up - Product Wise

Asset Break-Up

Species Break-Up

Operational Metrics

    Select a Metric
    • R&D as a % of Total Sales (%)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Sequent Scientific Ltd. Business

    SeQuent, operating as Alivira Animal Health, is a global pharmaceutical company established in 2002. It focuses on developing products for livestock, poultry, and companion animals to create value in the animal health space.

    Sequent Scientific major competitors are Zota Health Care, Guj. Themis Biosyn, Gufic Biosciences, Orchid Pharma, Unichem Lab, Indoco Remedies, Panacea Biotec.
    Market Cap of Sequent Scientific is ₹4,564 Crs.
    While the median market cap of its peers are ₹3,599 Crs.

    Sequent Scientific seems to be less financially stable compared to its competitors.
    Altman Z score of Sequent Scientific is 5.07 and is ranked 5 out of its 8 competitors.

    Company Filing

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material